Cargando…
Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation
BACKGROUND: Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile infection (rCDI). The use of freeze-dried, encapsulated donor material for FMT (cap-FMT) allows for an easy route of administration and remains clinically effective in the majority of rCD...
Autores principales: | Staley, Christopher, Kaiser, Thomas, Vaughn, Byron P., Graiziger, Carolyn T., Hamilton, Matthew J., Rehman, Tauseef ur, Song, Kevin, Khoruts, Alexander, Sadowsky, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145197/ https://www.ncbi.nlm.nih.gov/pubmed/30227892 http://dx.doi.org/10.1186/s40168-018-0549-6 |
Ejemplares similares
-
Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection
por: Staley, Christopher, et al.
Publicado: (2019) -
Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation
por: Staley, Christopher, et al.
Publicado: (2016) -
A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis
por: Vaughn, Byron P, et al.
Publicado: (2019) -
Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation
por: Shankar, Vijay, et al.
Publicado: (2014) -
Lower endoscopic delivery of freeze-dried intestinal microbiota results in more rapid and efficient engraftment than oral administration
por: Staley, Christopher, et al.
Publicado: (2021)